等待开盘 10-29 09:30:00 美东时间
0.000
0.00%
Liminatus Pharma, Inc. (NASDAQ:LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it has entered into a Memorandum of Understanding
10-28 01:38
(来源:机器之心) 机器之心原创 编辑:Panda、泽南 开发者不能再内向了:要会和客户同事说,会和 AI 说。 「我想说的很明确:现在我们有了更多学习新技...
10-24 11:39
近日,复旦大学附属华山医院史之峰教授,周良辅院士团队和安科生物参股公司上海元宋生物技术有限公司(元宋生物)在国际肿瘤免疫治疗权威期刊《Journal for ...
10-14 09:16
New data in human cancer cell lines provides confirmation of pan-KRAS mutation inhibition with inhibition of G12D, G12V, G12R, G12C, G13C, G12A, Q61H, and G13D mutationsCompany Reports first evidence of gastric cancer
09-30 20:41
(来源:中国炼铁网) 据力拓官网的消息称,8月22日(几内亚当地时间),力拓西芒杜项目发生一起悲剧。力拓西芒杜项目一家分包商的一名雇员在恩泽雷科雷(Nzéré...
08-25 14:22
Silexion Therapeutics Corp. (NASDAQ:SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced groundbreaking new
07-31 21:57
(转自:ETF炼金师) 美国时间7月8日,美股三大指数出现震荡分化的走势,中国资产则表现出强劲的上涨势头。纳斯达克中国金龙指数一度上涨超过2%,而两倍做多...
07-09 12:00
The latest update is out from Christie ( ($GB:CTG) ). Christie Group plc’s advi...
07-01 19:55
Cegeka Groep NV ("Cegeka") and Computer Task Group, Incorporated (NASDAQ:CTG) ("CTG") announced today that Chicago Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of Cegeka, has
2023-09-21 18:57
NEW YORK, Aug. 9, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
2023-08-10 11:16